FDA Loosens Reins on Crisis Lab Tests for Speed
Published Date: 9/23/2025
Notice
Summary
The FDA just released new rules about how they’ll handle certain lab tests during emergencies, like a health crisis. If you make or use these tests, this guidance explains when the FDA might relax some rules to help get tests out faster. This means quicker access to important tests without waiting for all the usual approvals, saving time and possibly money during emergencies.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
FDA may relax rules for IVD makers
The FDA guidance explains the factors it will use to decide whether to issue an enforcement policy that allows manufacturers to offer certain unapproved in vitro diagnostic (IVD) tests or unapproved uses of approved IVD tests during a Section 564 declared emergency. If the FDA issues such an enforcement policy, makers could be allowed to provide tests without completing the usual approvals during that declared emergency.
Faster access to certain tests in emergencies
During a Section 564 declared emergency, the FDA may issue enforcement policies that allow certain unapproved IVD tests or unapproved uses of approved tests to be offered. You could get access to some lab tests sooner in that declared emergency because the guidance explains when the FDA might permit those offerings.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in